Next Up:
0:00
0:00
-
Listen Listen
Health
Federal health officials have identified a single supplier of the produce from Mexico that was served in Taco Bell restaurants in five states.
Listen
3:43
Sponsored message
More Stories
-
The sometimes uncomfortable sensations we feel in our teeth may be an evolutionary holdover from the scaly exteriors of ancient armored fish.Listen 4:00
-
The agency is taking steps to remove prescription fluoride products that children swallow. But researchers who study fluoride say it's not harmful and some kids need the treatments.
-
Five months after the Eaton Fire, soil tests show elevated levels of lead and other toxic metals in and around the affected areas.
-
L.A. County is offering free tests after recent analysis showed high levels of lead downwind of the January fire that devastated Altadena.Listen 0:44
-
Catholic hospitals run 20% of California’s maternity wards. Their policies generally prohibit abortion, even in miscarriage, as long as a heartbeat can be detected.
-
The FDA says 26 people, nine of whom were hospitalized, have gotten sick across 15 states. It is still figuring out where the cucumbers were distributed — and warning people to take extra precautions.
-
L.A. County’s Department of Public Health sent notice to 39 organizations that their contracts to provide STD and HIV prevention services will be terminated.
-
Nearly 135,000 residents will be notified next week as part of the first wave of the county’s medical debt relief program.
-
Weight loss drugs Ozempic and Wegovy would no longer be covered by California’s health insurance for low-income people under the governor’s proposal.
-
To save more than $5 billion, the California governor wants to shut down new enrollment for adults who lack legal status and charge premiums. The Legislature has resisted such changes.
-
Gov. Gavin Newsom will seek to regulate pharmaceutical middlemen that he blames for driving up prescription drug costs in California, eight months after vetoing a similar bill.
-
President Trump wants to lower drug prices in the U.S. by tying them to the prices paid in other developed countries. The pharmaceutical industry has long opposed the approach.Listen 3:47